COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 177: Articles 1761-1770  | Next

Modelling the potential use of pre-exposure prophylaxis to reduce nosocomial SARS-CoV-2 transmission
Stewart, L., Evans, S., Brevini, T., Sampaziotis, F., Illingworth, C.
10.1101/2024.12.27.24319372 — Posted: 2024-12-29
COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
mohammadi, s., isay, M. M., Khogali Osman, A., Widi Saraswati, P., Zuithoff, N. P. A., Weibel, D., Sturkenboom, M., Ahmadizar, F.
10.1101/2024.12.27.24319417 — Posted: 2024-12-29
Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System
Appaneal, H., Lopes, V. V., Puzniak, L., Zasowski, E., Jodar, L., McLaughlin, J., Caffrey, A.
10.1101/2024.12.26.24319566 — Posted: 2024-12-29
IMPACT OF COVID-19 ON EDUCATION: LATEST TRENDS IN K-12 EDUCATION IN THE WORLD
Bakhsh, K., Shoukat, R., Huang, Q.
10.1101/2024.12.26.24319675 — Posted: 2024-12-29
COVID-19 pandemic reshaped seasonal patterns and age distributions of respiratory viruses
He, M., Gao, L., Hu, Y., Liang, S., Tang, J., Zhao, Y., Zhang, Y., Deng, N., Zhou, C., Wang, H., Lan, X., Wang, Z., Li, Y., Xu, K.
10.1101/2024.12.25.24319311 — Posted: 2024-12-28
A Virtual Music Mindfulness Tool for Individuals of African descent during COVID-19
Igbinobaro, E., Watts, A., Oshodi, O., Emile, M., Soumare, A., Takyi, P., Haida, T., Washington, H., Allsop, A. S.
10.1101/2024.12.23.24305623 — Posted: 2024-12-27
Detecting SARS-CoV-2 Cryptic Lineages using Publicly Available Whole Genome Wastewater Sequencing Data
Suarez, R., Gregory, D. A., Baker, D. A., Rushford, C. A., Hunter, T. L., Minor, N. R., Russ, C. M., Copen, E. E., OConnor, D. H., Johnson, M. C.
10.1101/2024.12.24.24319568 — Posted: 2024-12-27
Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1
Liu, J., Yu, Y., Yang, S., Jian, F., Song, W., Yu, L., Shao, F., Cao, Y.
10.1101/2024.12.27.630350 — Posted: 2024-12-27
The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
Wu, X.-J., Oppelt, K. A., Fan, M., Marie, M. A., Swyers, M. M., Williams, A. J., Lemasson, I. M., Roper, R. L., Bolin, P., Yang, L. V.
10.1101/2024.12.26.630404 — Posted: 2024-12-27
Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients
Wanjiku, p. N., Orindi, B., Kimotho, J., Sayed, S., Shah, R., Saleh, M., Mwacharo, J., Maronga, C., Olouch, V., Karanu, A., Shah, J., Nneka, Z., Ochola-Oyier, L. I., Abdi, A. I., Dunachie, S., Bejon, P., Nduati, E., Ndungu, F. M.
10.1101/2024.12.22.24319505 — Posted: 2024-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).